Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients

Mostrar otras versiones (1)

BACKGROUND: Hydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Elizabeth, Giles, Jon T., Perez-Recio, Thania, Pina, Paloma, Depender, Christopher, Gartshteyn, Yevgeniya, Askanase, Anca, Bathon, Joan, Geraldino-Pardilla, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259909/
https://www.ncbi.nlm.nih.gov/pubmed/34230925
http://dx.doi.org/10.21203/rs.3.rs-650818/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259909/
https://www.ncbi.nlm.nih.gov/pubmed/34230925
http://dx.doi.org/10.21203/rs.3.rs-650818/v1

Ejemplares similares